Tarek Elghetany, MD
Hematopathology
Texas Children's Hospital
Professor of Pathology & Immunology and Pediatrics, Baylor College of Medicine
Idiomas: English
Departamentos:
Get to know Tarek Elghetany, MD
[person:personal_statement]
Dr. Elghetany has been studying the expression of the p53, p21 waf, WT-1, caspase-3, survivin, and Ki 67 in inherited and acquired bone marrow failure syndromes in an attempt to gain insight into the mechanism of cytopenias. Also, he is investigating the possible use of expression patterns to help differentiate inherited from acquired cytopenias. He continues to study patients with inherited bone marrow failure syndromes using cytochemistry and flow cytometry in order to find changes that could be predictive of the development of myelodysplastic syndrome or acute leukemia.
Educacion
,
,
,
Organizaciones
,
,
,
,
* Texas Children’s Hospital physicians’ licenses and credentials are reviewed prior to practicing at any of our facilities. Sections titled From the Doctor, Professional Organizations and Publications were provided by the physician’s office and were not verified by Texas Children’s Hospital.
Chu V, Curry JL, Elghetany MT, Curry CV. MonoMAC versus idiopathic CD4+ lymphocytopenia. Comment to Haematologica. 2011;96(8):1221-5. Haematologica 97(4):e9-11, 2.